Finance News – Clinical Trial
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Act...
The FDA’s suspension of a key clinical study for Rocket Pharmaceuticals has led to a substantial decline in the company’s market value and the initiation of investor legal proceedi...
Read Full Article →Sarepta Therapeutics Stock Tumbles on Report of Third Death in Clinical Trial
The recent report of a fatality in the ongoing clinical study has adversely affected the company’s market valuation, reflecting investor concerns about potential risks and future f...
Read Full Article →Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
The success of a new obesity medication in China could challenge existing market leaders, potentially shifting investment dynamics within the pharmaceutical sector and impacting fu...
Read Full Article →BioXcel Therapeutics Receives Second Positive Recommendation from Data Safety Monitoring Board (DSMB...
The ongoing phase 3 study's progression, supported by positive safety evaluations, may enhance BioXcel Therapeutics' future revenue potential and investor confidence ahead of antic...
Read Full Article →